- Eye Opening
In recent years, drug-industry executive Martin Shkreli and Mylan, the makers of EpiPen, garnered infamy for their pricing strategies. Yet consumers remain largely in the dark about drug pricing. Atlantic editor Steve Clemons questions a knowledgeable panel about the opaque math behind drug pricing – and then presses for better solutions. getAbstract recommends this elucidating and timely, yet frequently digressing, discussion.
About the Speakers
Henry Aaron is a senior fellow with the Brookings Institution, a public policy organization. Elizabeth Fowler is a global health policy executive for Johnson & Johnson. Gail Wilensky is a senior fellow with Project HOPE, a worldwide health foundation. Steve Clemons is editor of AtlanticLIVE, the events branch of The Atlantic magazine.
Instant access to over 20,000 book summaries
Discover your next favorite book with getAbstract.
See prices >>
Stay up-to-date with emerging trends in less time.
Learn more >>